Author: Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
The European Union has launched a major initiative to boost artificial intelligence innovation. The InvestAI program will invest €200 billion to support research, development, and deployment of AI technologies across Europe. As part of the program, the EU plans to fund over 60 European companies that are committed to advancing AI solutions. The initiative also includes the creation of AI gigafactories, which will serve as hubs for large-scale AI development and production. The InvestAI program aims to make Europe a global leader in artificial intelligence. EU officials said the initiative will strengthen technological capabilities, create jobs, and enhance competitiveness in…
President Donald Trump has called for an end to the Ukraine Russia war, urging both countries to halt their ongoing conflict. The statement came after a meeting with Ukrainian President Volodymyr Zelenskyy, highlighting Trump’s push for a pause in hostilities. Trump said both Ukraine and Russia should “stop where they are” to prevent further destruction and loss of life. He emphasized the need for dialogue and negotiation to achieve peace. The former president’s remarks mark a renewed focus on diplomatic efforts in the region. During the meeting, Trump discussed potential measures to ease tensions and encouraged both leaders to consider…
A long-acting injection that prevents HIV is set to be approved for use in England and Wales, offering a major breakthrough in the fight to end new transmissions. The jab, administered every two months, provides an alternative to daily oral pills used for HIV prevention under the pre-exposure prophylaxis (PrEP) programme. In draft guidance released on Friday, the National Institute for Health and Care Excellence (NICE) recommended cabotegravir (CAB-LA) for adults and young people at risk of HIV who cannot take oral PrEP. The injection is already available on the NHS in Scotland. Health secretary Wes Streeting hailed the approval…
Nestlé will cut 16,000 jobs worldwide over the next two years as part of a major cost-cutting and restructuring plan aimed at accelerating growth. The layoffs — about 6% of its global workforce — include 12,000 white-collar and 4,000 manufacturing roles. “The world is changing and Nestlé needs to change faster,” said new CEO Philipp Navratil, who took over after Laurent Freixe was dismissed last month. The company plans to save 3 billion Swiss francs (£2.8 billion) by 2027, up from its previous target of 2.5 billion. Nestlé, which owns brands such as KitKat, Nescafé, and Purina, employs 4,200 people…
Rhizanthella is a remarkable orchid unlike any other—it spends its entire life beneath the surface of the soil. This leafless plant never emerges above ground, instead surviving by absorbing nutrients from a specialized fungus that connects both to the soil and to the roots of the broom bush, Melaleuca uncinata. The orchid first drew global attention in 1928 when a farmer in Western Australia unearthed it while ploughing his field. Nearly a century later, it remains one of the world’s most elusive plants. Finding it requires locating suitable habitat and then carefully scraping away soil to reveal its hidden blooms—small…
Alcohol consumption is a major driver of cancer across Europe, according to a new report by the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC). The agency urges stronger government policies to reduce drinking, which could prevent thousands of cancer cases and deaths each year. Within the European Union — the region with the highest alcohol consumption in the world — alcohol was responsible for over 111,000 new cancer cases in 2020. Globally, the figure reached an estimated 741,000 cases, with men accounting for nearly 70 percent of them. The economic burden is also severe. WHO estimates…
The United States and Finland have taken a major step to strengthen Arctic security cooperation with a $6 billion agreement to build new icebreakers. The deal highlights the growing partnership between the two nations as they address challenges in the Arctic region. The icebreakers are designed to navigate the icy waters of the Arctic, improving both nations’ capabilities to operate in extreme conditions. They will play a key role in supporting regional security, transportation, and scientific research. Officials from both countries emphasized that the Arctic is becoming increasingly important for global trade, environmental monitoring, and defense. “This partnership reflects our…
Scientists at the University of Cambridge’s Gurdon Institute have created embryo-like structures that produced human blood cells in the lab — a major step toward future regenerative therapies. The team grew the models from stem cells, without using eggs or sperm, allowing them to study the earliest stages of blood and heart development. “It was an exciting moment when the blood-red colour appeared in the dish – it was visible even to the naked eye,” said Dr Jitesh Neupane, the study’s lead author. The structures mimicked human embryos at about three to four weeks of development, forming key layers of…
Microplastics are everywhere — in our blood, lungs, guts, and even brains. Scientists estimate we carry about 5g inside us, but the health effects remain unclear. New research from Austria shows these particles can alter gut bacteria in ways linked to depression and cancer. “Reducing exposure where possible is wise,” said Dr Christian Pacher-Deutsch. Microplastics come from packaging, clothes, and tyres, and are small enough to enter our organs. Studies in mice show brain changes and behaviour shifts after exposure. Human studies have found plastics in arteries and brains, possibly raising heart and dementia risks. Experts warn more research is…
AstraZeneca has reached an agreement with Donald Trump’s administration to lower some US drug prices in exchange for tariff relief. Announced from the Oval Office, the deal mirrors one struck with Pfizer last week and forms part of Trump’s plan to reduce prescription costs through “most-favored-nation” pricing. Under the deal, AstraZeneca will sell certain medicines to Medicaid at the lowest prices offered in other developed countries. “For many years, Americans have paid the highest prices in the world,” Trump said. “This deal may cut prices to the lowest anywhere.” The company’s CEO, Pascal Soriot, joined the president for the announcement,…